Tiedemann Advisors’s ResMed RMD Stock Holding History

Tiedemann Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,475	Closed	-$281K	–	451
2018 Q4	$281K	Buy	+2,475	New	+$265K	0.01%	352

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tiedemann Advisors's RMD Position: Q1 2019 in Review

Tiedemann Advisors sold out of ResMed (RMD) in Q1 2019, closing a stake of 2,475 shares — an estimated $281K sold.

Tiedemann Advisors first reported a position in RMD in Q4 2018 and held it in 1 quarter. The position peaked at $281K in Q4 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

Tiedemann Advisors reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
Tiedemann Advisors sold 2,475 ResMed shares in Q1 2019, an estimated $281K.
Tiedemann Advisors first reported a position in ResMed in Q4 2018 and held it in 1 quarter.
Tiedemann Advisors's ResMed position peaked at $281K in Q4 2018.
477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Tiedemann Advisors's 13F filing for Q1 2019, filed 13 May 2019.